Ortoma Receives Orders Worth About SEK 173 Million From Johnson & Johnson MedTech
Bitget2026/10/26 16:59- Ortoma received orders worth approximately SEK 173 million from its global commercial partner DePuy Synthes/Johnson & Johnson MedTech.
- The orders cover 125 OTS Hip systems with associated components, primarily for Europe and the United States.
- Deliveries are scheduled throughout 2027, with orders evenly distributed across all four quarters.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Investors reportedly offering Anthropic allocation shares at premiums of up to 5% ahead of its IPO
According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.
Nvidia continues to plummet, losing $430 billion in market value over two days, with Microsoft temporarily reclaiming the world's second place.
On Tuesday, Nvidia closed down 5.5%, a decline significantly greater than other major tech stocks, making it a key factor dragging down the tech sector's performance. During intraday trading on Tuesday, Microsoft's market capitalization briefly surpassed Nvidia, making it the world's second largest publicly traded company by market value. However, after Anthropic released its office suite, Microsoft's losses widened, causing it to fall behind Nvidia once again.
Updated: CoreWeave Raises Revenue Forecasts, AI Demand Unfazed by Growing Doubts
TransUnion EVP Venkat Achanta reports sale of $2.36 million in common shares
Crypto prices
More
